معرفی
Alexandre Slater is a Research Fellow at the Cardiovascular Sciences department of the University of Birmingham, supported by the British Heart Foundation (BHF). His research focuses on platelet biology, particularly on glycoprotein VI (GPVI) receptor mechanisms, nanobody engineering for antithrombotic therapy, and platelet activation pathways in cardiovascular disease.
His primary research interests include Platelet Biochemistry, Glycoprotein VI structure and function, Receptor Pharmacology, and Nanobody Engineering for therapeutic applications. Dr. Slater's work contributes to Sustainable Development Goals related to good health and well-being through advancements in cardiovascular disease treatment.
His recent publication trend shows a strong focus on platelet receptor interactions, particularly GPVI, with increasing emphasis on nanobody-based therapeutic approaches. His research combines structural biology, biochemistry, and translational approaches to develop novel antithrombotic strategies with reduced bleeding risk.
- British Heart Foundation funding for multiple projects
- Medical Research Council (MRC) Industrial Strategy Challenge Fund support
- Collaborations with international researchers across cardiovascular science
Dr. Slater actively collaborates with leading researchers in platelet biology, including Watson S.P., Thomas M.R., and Poulter N. His work demonstrates strong translational potential with multiple projects focused on developing novel anti-thrombotic therapies based on nanobody technology.
